Literature DB >> 26398326

Role of the Timed Up and Go Test in Patients With Chronic Obstructive Pulmonary Disease.

Maath A Al Haddad1, Michelle John, Samia Hussain, Charlotte E Bolton.   

Abstract

PURPOSE: The Timed Up and Go (TUG) test is a measure of functional mobility. It is a short test and requires minimal space. We determined the potential role of TUG test as a measure of function in patients with chronic obstructive pulmonary disease (COPD) and compared with controls. Furthermore, we wanted to determine the association and reliability of TUG test time to fall history.
METHODS: Patients with COPD (n = 119) and controls with a smoking history (n = 58) were recruited. The TUG test, 6-minute walk distance and subsequent BODE score, spirometry, and history of falls were assessed. The TUG test was measured across observers and on separate days within the same individual.
RESULTS: The TUG test time was greater in patients, 11.9 ± 3.7 seconds, than controls, 9.5 ± 1.8 seconds (P < .001). The TUG test was inversely related to 6-minute walk distance in patients (r =-0.74) and controls (r =-0.71); P < .001. In patients, TUG test was related to BODE score (r = 0.53; P < .001) but not spirometry measurements. A receiver operator curve analysis of 0.77 in patients indicated reasonable ability for TUG test to indicate those who had fallen in the past year. A TUG of ≥12 seconds had 74% sensitivity and specificity for a history of a fall in the past year. Inter- and intraobserver values indicated minimal differences between measurements.
CONCLUSION: These results support a potential role for the TUG test to be incorporated into community COPD assessment to stratify patients functionally, particularly where time and space are limited. Future studies are required to assess impact of interventions on TUG test and determine the predictive ability to identify future falls.

Entities:  

Mesh:

Year:  2016        PMID: 26398326     DOI: 10.1097/HCR.0000000000000143

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  10 in total

1.  Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.

Authors:  Panaiotis Finamore; Martijn A Spruit; Jos M G A Schols; Raffaele Antonelli Incalzi; Emiel F M Wouters; Daisy J A Janssen
Journal:  Aging Clin Exp Res       Date:  2020-04-11       Impact factor: 3.636

2.  Harnessing Digital Health to Objectively Assess Functional Performance in Veterans with Chronic Obstructive Pulmonary Disease.

Authors:  He Zhou; Catherine Park; Olia Poursina; Mohsen Zahiri; Hung Nguyen; Ilse Torres Ruiz; Christina K Nguyen; Mon S Bryant; Amir Sharafkhaneh; Venkata D Bandi; Bijan Najafi
Journal:  Gerontology       Date:  2021-11-29       Impact factor: 5.597

3.  A simple and rapid test of physical performance inchronic obstructive pulmonary disease.

Authors:  Ali Mufraih Albarrati; Nichola S Gale; Stephanie Enright; Margaret M Munnery; John R Cockcroft; Dennis J Shale
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-02

4.  Diagnostic ability of the Timed Up & Go test for balance impairment prediction in chronic obstructive pulmonary disease.

Authors:  Chalerm Liwsrisakun; Chaicharn Pothirat; Warawut Chaiwong; Tanagorn Techatawepisarn; Atikun Limsukon; Chaiwat Bumroongkit; Athavudh Deesomchok; Theerakorn Theerakittikul; Pattraporn Tajarernmuang
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

5.  Balance assessment in people with COPD: An evidence-based guide.

Authors:  Marla K Beauchamp
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

6.  Association Between the Results of the Timed Up-and-Go Test Adjusted for Disease Severity and Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: a Pilot Study.

Authors:  Demetria Kovelis; Anna Raquel Silveira Gomes; Camila Mazzarin; Andrieli de Miranda; Silvia Valderramas
Journal:  Clinics (Sao Paulo)       Date:  2019-11-07       Impact factor: 2.365

Review 7.  Towards Personalized Management of Sarcopenia in COPD.

Authors:  Sophie I J van Bakel; Harry R Gosker; Ramon C Langen; Annemie M W J Schols
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-07

8.  Timed Up and Go: Reference Values for Community-Dwelling Older Adults with and without Arthritis and Non-Communicable Diseases: The Tromsø Study.

Authors:  Odd-Einar Svinøy; Gunvor Hilde; Astrid Bergland; Bjørn Heine Strand
Journal:  Clin Interv Aging       Date:  2021-02-23       Impact factor: 4.458

Review 9.  Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: A rapid review.

Authors:  Anne E Holland; Carla Malaguti; Mariana Hoffman; Aroub Lahham; Angela T Burge; Leona Dowman; Anthony K May; Janet Bondarenko; Marnie Graco; Gabriella Tikellis; Joanna Yt Lee; Narelle S Cox
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

10.  A TUG Value Longer Than 11 s Predicts Fall Risk at 6-Month in Individuals with COPD.

Authors:  Vivien Reynaud; Daniela Muti; Bruno Pereira; Annick Greil; Denis Caillaud; Ruddy Richard; Emmanuel Coudeyre; Frédéric Costes
Journal:  J Clin Med       Date:  2019-10-22       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.